| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 9857 | DOTA-Sargastrin |
9857.0001: 1 mg per vial 9857.0010: 10 mg per vial Please inquire for customized filling and bulk quantities.
|
|
Precursor for radiometal-labeled DOTA-Sargastrin
|
||
| Molar Mass: 2483.6 | ||
| C114H155N25O38 | ||
| CAS-RN not yet assigned | ||
| Colourless to off-white freeze-dried solid packaged in dark glass screw cap vials. | ||
| Purity: ≥ 95 % | ||
|
Certificates:
CoA; MS (identity) and HPLC (purity) |
||
|
Chemical Name: L-Phenylalaninamide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-L-glutamylglycyl-L-prolyl-L-tryptophyl-L-leucyl-L-glutamyl-L-glutamyl-L-glutamyl-L-glutamyl-L-glutamyl-L-alanyl-L-tyrosylglycyl-L-tryptophyl-L-norleucyl-L-α-aspartyl- |
||
|
Synonymes: DOTA-Gln-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Nle-Asp-Phe-NH2 |
||
|
Literature: 1. Laverman P. et al. Comparative biodistribution of 12 111In-labelled gastrin/CCK2 receptor-targeting peptides. Eur. J. Nucl. Med. Mol. Imaging 2011, 38, 1410 - 1416 |
||
| 2. Aloj L. et al. Comparison of the binding and internalization properties of 12 DOTA-coupled and 111In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607. Eur. J. Nucl. Med. Mol. Imaging 2011, 38, 1417-1425. | ||
| date of product catalogue issue: 05 April 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1